Homocysteine, cardiovascular inflammation, and myocardial remodeling

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 10, Issue 4, 2010, Pages 241-245

  Finch, Jennifer M ^a   Joseph, Jacob ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Heart failure; Homocysteine; Remodeling

Indexed keywords

HOMOCYSTEINE;

AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFLAMMATION; HEART FAILURE; HEART FUNCTION; HEART SURGERY; HUMAN; MAST CELL; NONHUMAN; PATHOGENESIS; VITAMIN SUPPLEMENTATION;

EID: 79951592065     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152910793743887     Document Type: Article

References (46)

1. McCully, K.S. Vascular pathology of hyperhomocysteinemia: implications for the development of arteriosclerosis. Am. J. Cardiovasc. Pathol., 1969, 56, 111-128.
2. Owan, T.E.; Hodge, G.O.; Herges, R.M.; Jacobsen, S.J.; Roger, V.L.; Redfield, M.M. Trends in prevalence and outcome of heart failure with preserved ejection fractions. N. Engl. J. Med., 2006, 355(3), 251-259.
3. Ho K.K.; Pinsky J.L.; Kannell W. B.; Levy D. The Epidemiology of heart failure: The Framingham Study. J. Am. Coll. Cardiol., 1993, 22(4 suppl A), 6A-13A.
4. Kannel, W. Incidence and epidemiology of heart failure. Heart Fail Rev., 2000, 5, 167-173.
5. Roger, V.; Weston, S.; Redfield, M.; Hellermann-Homan, J.; Killian, J.; Yawn, B.P.; Jacobsen, S.J. Trends in heart failure incidence and survival in a community-based population. JAMA, 2004, 292, 344-350.
6. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA, 2002, 288, 2015-2022.
7. Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular: evidence on causality from a meta-analysis. BMJ, 2002, 325(7374), 1202.
8. Kenchaiah, S.; Narula, J.; Vasan, R.S. Risk factors for heart failure. Med. Clin. North Am., 2004, 88, 1145-1172.
9. Vasan, R.S.; Beiser, A.; D'Agostino, R.B.; Levy, D.; Selhub, J.; Jacques, P.F.; Rosenberg, I.H.; Wilson, P.W. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA, 2003, 289, 1251-1257.
10. Gibelin, P.; Serre, S.; Candito, M.; Houcher, B.; Berthier, F.; Baudouy M. Prognostic value of homocysteinemia in patients with congestive heart failure. Clin. Chem. Lab. Med., 2006, 44(7), 813-816.
11. Naruszewicz, M.; Jankowska, E.A.; Zyminski, R.; Bukowska, H.; Millo, B.; Banasiak, W.; Ponikowski, P. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance-pilot study. Atherosclerosis, 2007, 194(2), 408-414.
12. Herrmann, M.; Kindermann, I.; Muller, S.; Georg, T.; Kindermann, M.; Bohm, M.; Herrmann, W. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin. Chem., 2005, 51(8), 1512-1515.
13. Frantzen, F.; Faaren, A.L.; Alfheim, I.; Nordhei A.K. Enzymes conversion immunoassay for determining total homocysteine in plasma or serum. Clin. Chem., 1998, 44, 311-316.
14. Selhub, J. Homocysteine metabolism. Ann. Rev. Nutr., 1999, 19, 217-46.
15. Vizzardi, E.; Bonadei, I.; Zanini, G.; Frattini, S.; Fiorina, C.; Raddino, R.; Dei, Cas, L. Homocysteine and Heart Failure: an overview. Recent Pat. Cardiovasc. Drug Discov., 2009, 4, 15-21.
16. Kluijtmans, L.A.; Young, I.S.; Boreham, C.A.; Murray, L.; McMaster, D.; McNulty, H.; Strain, J.J.; McPartlin, J.; Scott, J.M.; Whitehead, A.S. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood, 2003, 101, 2483-2488.
17. McMurray, J.; Pfeffer, M.A. New therapeutic options in congestive heart failure: Part I. Circulation, 2002, 105(17), 2099-2106.
18. Joseph, J.; Washington, A.; Joseph, L.; Koehler, L.; Fink, L.; Hauer-Jensen, M.; Kennedy, R.H. Hyperhomocysteinemia leads to adverse cardiac remodeling and dysfunction in hypertensive rats. Am. J. Physiol., 2002, 283, H2567-H2574.
19. Joseph, J.; Joseph, L.; Shekhawat, N.; Devi, S.; Wang, J.; Melchert, R.; Hauer-Jensen, M.; Kennedy, R.H. Hyperhomocysteinemia leads to pathologic ventricular hypertrophy in normotensive rats. Am. J. Physiol. Heart Circ. Physiol., 2003, 285(2), H679-86.
20. Devi, S.; Richard, H.K.; Joseph, L.; Nawal, S.S.; Russell, B.M.; Joseph, J. Effects of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc. Pathol., 2006, 15, 75-82.
21. Miller, A.; Mujumdar, V.; Palmer, L.; Bower, J.D.; Tyagi, S.C. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am. J. Hyperten., 2002, 15(2 Pt 1), 157-163.
22. Walker, E.; Black, J.; Parris, C.; Bryda, E.C.; Cansino, S.; Hunt, L.; Chappel, J.; Wehner, P.; Studeny, M.; Wright, G.L. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann. Clin. Lab. Sci., 2004, 34, 175-180.
23. Joseph, J.; Handy, D.E.; Loscalzo, J. Quo vadis: whither homocysteine research?. Cardiovasc. Toxicol., 2009, 9(2), 53-63.
24. Torre-Amione, G.; Kapadia, S.; Lee, J.; Durand, J.B.; Bies, R.D.; Young, J.B.; Mann, D.L. Tumor necrosis factor-alpha and tumor necrosis factor receptor in the failing human heart. Circulation, 1996, 93, 704-711.
25. Libby, P.; Ridker, P.M.; Hansson, G.K. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol., 2009, 54(23), 2129-2138.
26. Hofmann, M.A.; Lalla, E.; Lu, Y.; Gleason, M.R.; Wolf, B.M.; Tanji, N.; Ferran, L.J.; Jr, Kohl, B.; Rao, V.; Kisiel, W.; Stern, D.M. Schmidt, A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest., 2001, 107(6), 675-83.
27. Desai, A.; Lankford, H.A.; Warren, J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation, 2001, 25(3), 179-186.
28. Poddar, R.; Sivasubramanian, N.; DiBello, P.M.; Robinson, K.; Jacobsen, D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation, 2001, 103(22), 2717-2723.
29. Welch, G.N.; Upchurch, G.R.; Jr, Farivar, R.S.; Pigazzi, A.; Vu, K.; Brecher, P.; Keaney, J.F.; Jr, Loscalzo, J. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc. Assoc. Am. Phys., 1998, 110(1), 22-31.
30. Gori, A.M.; Corsi, A.M.; Fedi, S, Gazzini, A.; Sofi, F.; Bartali, B.; Bandinelli, S.; Gensini, G.F.; Abbate, R.; Ferrucci, L. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am. J. Clin. Nutr., 2005, 82(2), 335-341.
31. Bleie, Ø.; Semb, A.G.; Grundt, H.; Nordrehaug, J.E.; Vollset, S.E.; Ueland, P.M.; Nilsen, D.W.; Bakken, A.M.; Refsum, H.; Nygård, OK. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J. Intern. Med., 2007, 262(2), 244-253.
32. Ueland, P.M.; Nygard, O.; Vollset, S.E.; Refsum, H. The hordaland homocysteine studies. Lipids, 2001, 36(suppl), S33-S39.
33. Schofield, R.S.; Wessel, T.R.; Walker, T.C.; Cleeton, T.S.; Hill, J.A.; Aranda, J.M.; Jr. Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations. Clin. Cardiol., 2003, 26, 407-410.
34. Herrmann, M.; Muller, S.; Kinderman, I.; Gunther, L.; Koning, J.; Bohm, M.; Hermann, W. Plasma vitamin B and their relationship to the severity of chronic heart failure. Am. J. Clin. Nutr., 2007, 85, 117-123.
35. Sundstrom, J.; Sullivan, L.; Selhub, J.; Benjamin, E.J.; D'Agostino, R.B.; Jacques, P.F.; Rosenberg, I.H.; Levy, D.; Wilson, P.W.F.; Vasan, R.S. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur. Heart J., 2004, 25, 523-530.
36. Bing, O.H.; Brooks, W.W.; Robinson, K.G.; Slawsky, M.T.; Hayes, J.A.; Litwin, S.E.; Sen, S.; Conrad, C.H. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J. Mol. Cell Cardiol., 1995, 27(1), 383-396.
37. Kennedy, R.H.; Melchert, R.B.; Joseph, J. Cardiovascular effects of hyperhomocysteinemia in conscious unrestrained rats. Am. J. Hypertens., 2006, 19(1), 94-97.
38. Moshal, K.S.; Tipparaju, S.M.; Vacek, T.P.; Kumar, M.; Singh, M.; Frank, I.E.; Patibandla, P.K.; Tyagi, N.,.;Rai, J.; Metreveli, N.; Rodriguez, W.E.; Tseng, M.T.; Tyagi, S.C. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am. J. Physiol. Heart Circ. Physiol., 2008, 295(2), H890-H897.
39. Mishra, P.K.; Tyagi, N.; Kundu, S.; Tyagi, S.C. MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem. Biophys., 2009, 55(3), 153-162.
40. Jahanyar, J.; Youker, K.A.; Loebe, M.; Assad-Kottner, C.; Koerner, M.M.; Torre-Amione, G.; Noon, G.P. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing heart. J. Surg. Res., 2007, 140(2), 199-203.
41. Joseph, J.; Kennedy, R.H.; Devi, S.; Wang, J.; Joseph, L.; Hauer- Jensen, M. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol., 2005, 288, H2541-H2545.
42. Bonaa, K.; Njolstad, I.; Ueland, P.; Schrimer, H.; Tverdal, A.; Steigen, T.; Wang, H.; Nordrehaug, J.; Arnesen, E.; Rasmussen, K. Homocysteine lowering and cardiovascular event after acute myocardial infarction. N. Engl. J. Med., 2006, 354 (15), 1578-1588.
43. Toole, J.F.; Malinow, M.R.; Chambless, L.E.; Spence, J.D.; Pettigrew, L.C.; Howard, V.J.; Sides, E.G.; Wang, C.H.; Stampfer, M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin for Stroke Prevention trial (VISP) randomized controlled trial. JAMA, 2004, 291, 565-575.
44. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med., 2006, 354, 1567-1577.
45. Spence, J.D.; Bang, H.; Chambless, L.E.; Stampfer, M. J. Vitamin Intervention for Stroke Prevention trial: an efficacy analysis. Stroke, 2005, 36, 2404-2409.
46. Joseph, J.; Joseph, L.; Devi, S.; Kennedy, R.H. Effect of antioxidant treatment on hyperhomocysteinemia-induced myocardial fibrosis and diastolic dysfunction. J. Heart Lung Transplant., 2008, 27(11), 1237-1241.